Semaglutide Powder Cas No.910463-68-2
CAS No.:910463-68-2
Product origin: Usually produced by recombinant DNA technology
Content specification: ≥98% (HPLC)
Detection method: RP-HPLC
Active ingredient: Semaglutide
Product fineness: 100-200 mesh
Product properties: White to off-white powder
Product packaging: 5mg, 10mg, 15mg, 20mg, 30mg
Product storage: Protected from light, dry, cool place, relative humidity ≤60%
Shelf life: 24 months
Products Description
Simeglutide comes from Xi'an Tihealth
Semaglutide Powder is a human glucagon like peptide-1 analog produced by biological fermentation through gene recombination technology. It stimulates insulin secretion in a glucose dependent manner by mediating the GLP-1 receptor, and is used for blood glucose control in adult patients with type II diabetes.
The long-term mechanism of Semaglutide Powder is based on structural modification. Connecting the lysine position at position 26 of the peptide chain to an 18 carbon fatty acid side chain modified carbon chain increases the molecular weight of Semaglutide Powder and enhances its affinity for albumin by 5-6 times, avoiding rapid clearance by the kidneys and preventing metabolic degradation, thus prolonging the half-life in vivo.
Products Advantages
Ultra long acting GLP-1 analogs can be made into two dosage forms, oral and injection. Oral preparations can be made once a day, while injection preparations can be made once a week
Produced using biotechnology methods, in compliance with GMP standards, and of comparable quality to the original research product
Products Function
The benefits of Semaglutide Powder to human body mainly focus on its two approved core indications, namely, improving the health status of patients with type 2 diabetes and assisting the management of chronic weight in adults. At the same time, Semaglutide Powder has additional benefits in cardiovascular protection, which can be divided into the following three categories:
1. Core benefits for patients with type 2 diabetes
Effective control of blood sugar with low risk of hypoglycemia
Protecting pancreatic beta cell function and delaying disease progression
Reduce the risk of cardiovascular adverse events
2. Core benefits of weight management
Significant and sustained weight loss, improvement in obesity related indicators
Improve obesity related comorbidities and reduce metabolic risk
Semaglutide Powder can indirectly improve various metabolic abnormalities caused by obesity:
-For patients with combined hypertension, it can assist in lowering blood pressure;
-For patients with concomitant dyslipidemia, triglyceride and low-density lipoprotein cholesterol (LDL-C) levels can be improved;
-For those with "prediabetes", the risk of developing type 2 diabetes can be reduced.
3. Indirect benefits related to medication convenience
Low medication frequency and high patient compliance
Positive impact on weight (for patients with diabetes)
It should be noted that:
The benefits of Semaglutide Powder need to be achieved through standardized medication under the guidance of a doctor, and should be accompanied by dietary control and exercise; At the same time, its use has contraindications (such as contraindications for patients with a history of medullary thyroid cancer) and potential adverse reactions (such as gastrointestinal reactions and thyroid tumor risk warnings), and its applicability must be strictly evaluated according to medical advice. Self medication is not allowed.
Products Application
The core application areas of Semaglutide Powder are as follows:
FEATURE 01
Treatment of diabetes (core indication)
FEATURE 02
Weight Management (Global Key Focus)
FEATURE 03
Risk prevention and control of cardiovascular diseases
FEATURE 04
Neurodegenerative diseases
FEATURE 05
Metabolic associated fatty liver disease (MASLD/MASH)
FEATURE 06
Other expansion area
Application Restrictions and Risk Warning
1.Contraindications:
Prohibited for patients with a history/family history of medullary thyroid cancer and type 2 multiple endocrine neoplasia.
2.Adverse reactions:
Common gastrointestinal reactions (nausea, vomiting, diarrhea).
Monitoring of risks such as pancreatitis (persistent abdominal pain) and tachycardia is necessary.
Products FAQ
Q: Is semaglutide a "miracle drug for weight loss"? Can ordinary people use it casually?
A: Not a miracle drug! It is a prescription drug and needs to be evaluated by a doctor.
Risk Warning: Misuse by non indications may lead to risks such as pancreatitis and hypoglycemia
Q: How long does it take to take to take effect? How many pounds can you lose in a month?
A: The effect varies from person to person:
Glucose control in diabetes: the blood sugar drops within 4 weeks, and the glycosylated hemoglobin (HbA1c) drops by 1.8%
Weight loss effect (foreign data):
Average weight loss: 17-18% (approximately 15-20 pounds/100kg base)
Q: What are the common side effects? How to alleviate it?
A: Gastrointestinal reactions (>30% of users): nausea, bloating, constipation (relieved within 1-2 weeks)
Mitigation methods:
Starting from a small dose (such as 0.25mg/week), avoid high-fat/spicy foods
The incidence of side effects in oral tablets is slightly lower than that in injections
Q: Who is absolutely not allowed to use it?
A: Taboo populations include:
History of medullary thyroid cancer/family history, multiple endocrine neoplasia type 2
Pancreatitis, severe liver and kidney damage, pregnant and lactating women
Q: Can I drink alcohol/have late night snacks during medication?
A：Alcohol: A small amount is acceptable, but alcohol tolerance may decrease (it is recommended to stop taking medication 1-2 days in advance for important occasions)
Midnight snack: Prohibited! Affects fasting absorption and reduces drug efficacy
Hot Tags: Semaglutide Powder Cas No.910463-68-2, China Semaglutide Powder Cas No.910463-68-2 manufacturers, suppliers, factory, Earthworm Protein Peptide, Glutathione Powder, Goji Berry Peptide, peptides, Soybean Peptide
You Might Also Like
Send Inquiry